Subtitle
Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.
Subtitle
Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.
Proto therapy Time
July 2016
Executive summary
This study from Japan evaluated outcomes of PBT for locally recurrent parotid gland cancer. Ten patients were treated to 70.2 Gy equivalents in 32 fractions. With the median follow-up of 24 months, the study reported that the 1-year overall survival and local control rates were 80 %, and the 3-year overall survival and local control rates were 60 %, and no patient experienced grade 3-5 toxicities.
This study concluded that PBT could be applied effectively and safely for patients with locally recurrent parotid gland cancer.
Top cancer treatments
Related contents
Proton Therapy Publication
September 2024
The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.
Proton Therapy Publication
May 2024
Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic Carcinoma.
Proton Therapy Publication
June 2024
Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.
Proton Therapy Publication
May 2024
Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.
Proton Therapy Publication
August 2024
Proton Therapy in The Treatment of Head And Neck Cancers- Review.
Webinar
Phase III randomized trial of IMPT versus IMRT for the treatment of head and neck oropharyngeal carcinoma (OPC)
An Interview with Dr. Steven Frank
Steven
Frank
Proton Therapy Publication
June 2024
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.